Target joint resolution in patients with haemophilia A receiving long-term prophylaxis with BAY 94-9027

Mark T. Reding, Ingrid Pabinger, Shadan Lalezari, Elena Santagostino, Maria Elisa Mancuso

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e201-e204
JournalHaemophilia
Volume26
Issue number4
DOIs
Publication statusPublished - 2020

Keywords

  • BAY 94-9027
  • bleeding
  • damoctocog alfa pegol
  • haemophilia A
  • PROTECT VIII trial
  • target joint

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)

Cite this